1 reports of this reaction
2.2% of all ASPIRIN, CAFFEINE reports
#5 most reported adverse reaction
ATAXIA is the #5 most commonly reported adverse reaction for ASPIRIN, CAFFEINE, manufactured by CVS Pharmacy. There are 1 FDA adverse event reports linking ASPIRIN, CAFFEINE to ATAXIA. This represents approximately 2.2% of all 45 adverse event reports for this drug.
Patients taking ASPIRIN, CAFFEINE who experience ataxia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ATAXIA is a less commonly reported adverse event for ASPIRIN, CAFFEINE, but still significant enough to appear in the safety profile.
In addition to ataxia, the following adverse reactions have been reported for ASPIRIN, CAFFEINE:
The following drugs have also been linked to ataxia in FDA adverse event reports:
ATAXIA has been reported as an adverse event in 1 FDA reports for ASPIRIN, CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ATAXIA accounts for approximately 2.2% of all adverse event reports for ASPIRIN, CAFFEINE, making it a notable side effect.
If you experience ataxia while taking ASPIRIN, CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.